15-Keto-17-phenyl trinor Prostaglandin F2α is approved as an ocular hypotensive agent; it causes a slight but measurable reduction in intraocular pressure in normal cynomolgus monkeys at a dose of 1 μg/eye; its analog, 15-keto latanoprost (15-keto-17-phenyl-13,14-dihydro trinor PGF2α isopropyl ester), acts as a miotic agent in normal cat eyes, reducing pupil diameter by 8 mm at a dose of 5 μg/eye.